Related Experiment Videos
Augmentation of cellular immunity by kigamicin D.
Toru Masuda1, Shunichi Ohba, Manabu Kawada
1Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center, 18-24 Miyamoto, Numazu-shi, Shizuoka 410-0301, Japan. masudat@bikaken.or.jp
The Journal of Antibiotics
|July 13, 2006
Summary
Kigamicin D did not suppress immune responses but instead boosted cellular immunity against specific antigens. This natural compound enhances the body's ability to fight infections by stimulating delayed-type hypersensitivity.
Area of Science:
- Immunology
- Pharmacology
Background:
- Immunosuppressive agents can hinder the body's defense mechanisms.
- Understanding the immunomodulatory effects of natural compounds is crucial for therapeutic development.
Purpose of the Study:
- To investigate the immunomodulatory effects of Kigamicin D.
- To determine if Kigamicin D possesses immunosuppressive or immunostimulatory properties.
Main Methods:
- In vitro assays: mixed lymphocyte culture reaction and mitogen-induced lymphocyte blastogenesis.
- In vivo assays: graft-versus-host reaction and delayed-type hypersensitivity response to sheep red blood cells.
- Assessment of natural killer cell activity in spleen cells.
Main Results:
- Kigamicin D showed no immunosuppressive activity in vitro or in vivo.
- Natural killer cell activity remained unaffected by Kigamicin D administration.
- A significant stimulation of delayed-type hypersensitivity response was observed across various dosages.
Conclusions:
- Kigamicin D does not exhibit immunosuppressive effects.
- Kigamicin D enhances cellular immunity, specifically the delayed-type hypersensitivity response.
- Kigamicin D may be a potential therapeutic agent for modulating immune responses to specific antigens.